Tag: clinical trials

Global Companies

AI Revolutionizing Drug Development: AstraZeneca CEO Shares Game-Changing Insights

The AstraZeneca CEO just dropped major revelations about AI transforming how new medicines are created – from spotting targets faster...

05/06/2026

6 views

Read More

Market News

Replimune Resubmits Melanoma Drug Following FDA Leadership Shift

After two rejections, Replimune is resubmitting its promising melanoma drug following major FDA leadership changes. Could this be the breakthrough...

29/05/2026

4 views

Read More

Market News

FDA Fast Tracks Psychedelic Drugs For Mental Health Treatment

The FDA just hit the accelerator on psychedelic medicines that could transform how we treat severe depression and PTSD. With...

27/05/2026

4 views

Read More

Global Companies

Iambic Therapeutics AI Breakthroughs Reshaping Drug Discovery 2026

One biotech company just moved from AI discovery to clinical trials in record time with impressive tumor-fighting results. What does...

19/05/2026

10 views

Read More

Global Companies

Bristol Myers Squibb Partners With China’s Hengrui to Boost Drug Pipeline

Bristol Myers Squibb is sending experimental drugs to China for faster testing in a groundbreaking new deal with Hengrui Pharma....

15/05/2026

4 views

Read More

Market News

BioAge Labs Stock: Why Shares Could Double on New Anti-Aging Data

Wall Street is buzzing about a small biotech name focused on aging and inflammation. With key data readouts coming soon,...

13/05/2026

3 views

Read More

Market News

Lp(a) Drugs: New Hope for Preventing Heart Attacks from Pharma Giants

Pharma giants are racing to launch drugs targeting a dangerous, often overlooked form of cholesterol that genetics lock in place....

28/04/2026

9 views

Read More

Market News

Hope for Pancreatic Cancer: New Pill Shows Promising Results

When a former senator faced a dire Stage 4 pancreatic cancer diagnosis with months to live, an experimental daily pill...

11/04/2026

5 views

Read More

Market News

AstraZeneca Stock Surges on Major COPD Drug Trial Success

AstraZeneca just announced a surprise win in late-stage trials for a new COPD treatment that succeeded where others stumbled. The...

27/03/2026

4 views

Read More

Growth Picks

2026 Small-Cap Biotech Catalysts: Goldman’s Top Picks

As 2025 wraps up, investors are eyeing a blockbuster year for small-cap biotechs. With major Phase 2 data, pivotal trial...

28/12/2025

166 views

Read More